Cytosorbents (CTSO) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.36% |
| Dec 31, 2025 | -38.82% |
| Sep 30, 2025 | -20.11% |
| Jun 30, 2025 | 18.89% |
| Mar 31, 2025 | 27.52% |
| Dec 31, 2024 | -1.49% |
| Sep 30, 2024 | 24.95% |
| Jun 30, 2024 | 6.17% |
| Mar 31, 2024 | 6.01% |
| Dec 31, 2023 | 6.73% |
| Sep 30, 2023 | -16.00% |
| Jun 30, 2023 | 4.62% |
| Mar 31, 2023 | -11.20% |
| Dec 31, 2022 | 30.12% |
| Sep 30, 2022 | -31.95% |
| Jun 30, 2022 | -28.99% |
| Mar 31, 2022 | -28.47% |
| Dec 31, 2021 | -5.64% |
| Sep 30, 2021 | -10.76% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | -7.39% |
| Dec 31, 2020 | 29.47% |
| Sep 30, 2020 | 24.21% |
| Jun 30, 2020 | 2.33% |
| Mar 31, 2020 | 1.89% |
| Dec 31, 2019 | 31.15% |
| Sep 30, 2019 | 0.93% |
| Jun 30, 2019 | 16.44% |
| Mar 31, 2019 | 5.59% |
| Dec 31, 2018 | -76.23% |
| Sep 30, 2018 | -58.49% |
| Jun 30, 2018 | -80.20% |
| Mar 31, 2018 | -58.49% |
| Dec 31, 2017 | -82.40% |
| Sep 30, 2017 | -47.58% |
| Jun 30, 2017 | -47.58% |
| Mar 31, 2017 | -43.10% |
| Dec 31, 2016 | -80.20% |
| Sep 30, 2016 | -55.18% |
| Jun 30, 2016 | -61.54% |
| Mar 31, 2016 | -47.58% |
| Dec 31, 2015 | -58.49% |
| Sep 30, 2015 | -51.57% |
| Jun 30, 2015 | -55.18% |